DK518788A - Thrombolytisk middel - Google Patents

Thrombolytisk middel

Info

Publication number
DK518788A
DK518788A DK518788A DK518788A DK518788A DK 518788 A DK518788 A DK 518788A DK 518788 A DK518788 A DK 518788A DK 518788 A DK518788 A DK 518788A DK 518788 A DK518788 A DK 518788A
Authority
DK
Denmark
Prior art keywords
thrombolytic agent
urokinase
plasminogen
lys
pro
Prior art date
Application number
DK518788A
Other languages
English (en)
Other versions
DK518788D0 (da
Inventor
Vijay Vir Kakkar
Michael Finbarr Scully
Vincent John Ellis
Yoichi Watahiki
Original Assignee
Thrombosis Research Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thrombosis Research Trust filed Critical Thrombosis Research Trust
Publication of DK518788D0 publication Critical patent/DK518788D0/da
Publication of DK518788A publication Critical patent/DK518788A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK518788A 1987-09-18 1988-09-16 Thrombolytisk middel DK518788A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878721951A GB8721951D0 (en) 1987-09-18 1987-09-18 Organic compounds

Publications (2)

Publication Number Publication Date
DK518788D0 DK518788D0 (da) 1988-09-16
DK518788A true DK518788A (da) 1989-03-19

Family

ID=10623981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK518788A DK518788A (da) 1987-09-18 1988-09-16 Thrombolytisk middel

Country Status (11)

Country Link
EP (1) EP0307847B1 (da)
JP (1) JP2820699B2 (da)
AT (1) ATE82860T1 (da)
AU (1) AU623347B2 (da)
CA (1) CA1337046C (da)
DE (1) DE3876348T2 (da)
DK (1) DK518788A (da)
ES (1) ES2053658T3 (da)
GB (1) GB8721951D0 (da)
GR (1) GR3007194T3 (da)
NZ (1) NZ226217A (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2764264B2 (ja) * 1987-10-01 1998-06-11 株式会社ミドリ十字 線溶活性増強剤
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
AT402263B (de) * 1991-06-20 1997-03-25 Immuno Ag Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
AU4661493A (en) * 1992-07-01 1994-01-31 Beth Israel Hospital Boston Enhancement of thrombolytic therapy with deglycosylated plasminogen
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel
US7202066B2 (en) 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
CN106890318A (zh) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 一种预防和治疗糖尿病性心脏病的新方法
TWI624268B (zh) * 2015-12-18 2018-05-21 Talengen Institute Of Life Sciences Co Ltd 纖溶酶原在製備藥劑上的用途及包括纖溶酶原之藥劑
US11154595B2 (en) * 2016-12-15 2021-10-26 Talengen International Limited Method for preventing and treating pulmonary fibrosis
WO2018107688A1 (zh) * 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种预防和治疗脂肪肝的方法
WO2018107707A1 (zh) * 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种改善心脏病变的方法
US11207387B2 (en) 2016-12-15 2021-12-28 Talengen International Limited Method and drug for preventing and treating obesity
JP7175270B2 (ja) 2016-12-15 2022-11-18 タレンゲン インターナショナル リミテッド グルカゴン、インスリンを正常なバランスに戻らせる方法
CA3067890A1 (en) 2017-06-19 2018-12-27 Talengen International Limited Method for regulating and controling glp-1/glp-1r and drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504921A1 (fr) * 1981-04-30 1982-11-05 Choay Sa Medicament nouveau constitue par un complexe aprotinine-plasmine et procede de preparation de ce nouveau complexe
IL80166A0 (en) * 1985-10-01 1986-12-31 American Home Prod Method of enhancing t-pa and scu-pa production

Also Published As

Publication number Publication date
ES2053658T3 (es) 1994-08-01
AU2240088A (en) 1989-03-23
AU623347B2 (en) 1992-05-14
GR3007194T3 (da) 1993-07-30
JPH0283335A (ja) 1990-03-23
CA1337046C (en) 1995-09-19
EP0307847A2 (en) 1989-03-22
EP0307847A3 (en) 1990-03-07
EP0307847B1 (en) 1992-12-02
DE3876348D1 (en) 1993-01-14
NZ226217A (en) 1991-07-26
DK518788D0 (da) 1988-09-16
ATE82860T1 (de) 1992-12-15
DE3876348T2 (de) 1993-06-09
GB8721951D0 (en) 1987-10-28
JP2820699B2 (ja) 1998-11-05

Similar Documents

Publication Publication Date Title
DK518788D0 (da) Thrombolytisk middel
EP0230575A3 (de) Arzneimittel mit Antitumorwirkung das Hexadecylphosphocholin enthält
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
DK582188A (da) Stabile interferonkomplekser
ATE79252T1 (de) Zusammensetzung mit einem biologisch abbaubaren augenimplantat.
DK463989D0 (da) Farmaceutisk virksom kombination
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO160369C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 1,3-dihydro-6-(1-hydroksy-2-dimetylaminometyl-allyl)-7-hydroksy-furo(3,4-c)-pyridinderivater.
NO161802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.
NO166362C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive polyaminderivater.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
NO864130D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
NO883122D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
NO933235D0 (no) Anvendelse av en inhibitor for fremstilling av et medikament
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ES2019634B3 (es) Terapia con clorfeniramina.
FI883943A7 (fi) Muunnetut plasminogeeni aktivaattorit.
NO893784L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktiveimidazolderivater.
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
DE3867780D1 (de) 4-h-chinolizin-4-on-derivate mit therapeutischer aktivitaet.
NO882282D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment